University of Texas MD Anderson Cancer Center Researcher Discusses Findings in Thymic Cancer (S1701: A randomized phase II trial of carboplatin-paclitaxel with and without ramucirumab in patients with locally advanced, recurrent, or metastatic ...)

Media coverage

• Title	University of Texas MD Anderson Cancer Center Researcher Discusses Findings in Thymic Cancer (S1701: A randomized phase II trial of carboplatin-paclitaxel with and without ramucirumab in patients with locally advanced, recurrent, or metastatic ...)
  Media name/outlet	Angiogenesis Daily
  Country/Territory	United States
  Date	07/17/24
  Persons	Martin Edelman